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Background: In Denmark, a nationwide screening program for colorectal cancer was imple-
mented in March 2014. Along with this, a clinical database for program monitoring and research 
purposes was established.
Objective: The aim of this study was to estimate the agreement and validity of diagnosis and 
procedure codes in the Danish Colorectal Cancer Screening Database (DCCSD).
Methods: All individuals with a positive immunochemical fecal occult blood test (iFOBT) 
result who were invited to screening in the first 3 months since program initiation were identi-
fied. From these, a sample of 150 individuals was selected using stratified random sampling 
by age, gender and region of residence. Data from the DCCSD were compared with data from 
hospital records, which were used as the reference. Agreement, sensitivity, specificity and 
positive and negative predictive values were estimated for categories of codes “clean colon”, 
“colonoscopy performed”, “overall completeness of colonoscopy”, “incomplete colonoscopy”, 
“polypectomy”, “tumor tissue left behind”, “number of polyps”, “lost polyps”, “risk group of 
polyps” and “colorectal cancer and polyps/benign tumor”.
Results: Hospital records were available for 136 individuals. Agreement was highest for 
“colorectal cancer” (97.1%) and lowest for “lost polyps” (88.2%). Sensitivity varied between 
moderate and high, with 60.0% for “incomplete colonoscopy” and 98.5% for “colonoscopy 
performed”. Specificity was 92.7% or above, except for the categories “colonoscopy performed” 
and “overall completeness of colonoscopy”, where the specificity was low; however, the esti-
mates were imprecise.
Conclusion: A high level of agreement between categories of codes in DCCSD and hospital 
records indicates that DCCSD reflects the hospital records well. Further, the validity of the 
categories of codes varied from moderate to high. Thus, the DCCSD may be a valuable data 
source for future research on colorectal cancer screening.
Keywords: colorectal cancer screening, clinical database, data validity
Introduction
In Denmark, a nationwide screening program for colorectal cancer was implemented 
in March 2014. The program is administered by the five Danish regions, which are 
administrative units responsible for health care. Screening is offered biennial and 
free of charge to all citizens aged 50–74 years.1 The screening procedure is based 
on a single-sample immunochemical fecal occult blood test (iFOBT), which has 
been documented to detect invisible amounts of blood in stool samples, associated 
with bleeding lesions related to precancerous adenomas or bowel cancer, at early 
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stages of the disease.2,3 In the case of a positive test result 
(>100 ng/mL), a colonoscopy is performed,4 and if relevant, 
further treatment is provided.
In addition to the screening program, a clinical quality 
database, the Danish Colorectal Cancer Screening Data-
base (DCCSD), was established to monitor the quality of 
the screening program. The database comprises data from 
existing registries: the Invitation and Administration Module 
(IAM) for the screening program, the Danish National Patient 
Registry (DNPR) and the National Pathology Registry. Thus, 
all data are provided electronically and no data are entered 
manually in the DCCSD. With the screening program, a 
number of new codes were introduced for diagnoses and 
procedures performed within the screening program, mainly 
for data reported to the DNPR.
The primary aim of the DCCSD is to monitor the qual-
ity of the screening program and the secondary aim is to 
provide data for research purposes. To fulfill both aims, data 
completeness and validity must be high. As the screening 
program is newly established and the medical staffs have 
to report novel codes for procedures and diagnoses to the 
DNPR, the validity of data in the DCCSD is unknown. 
Therefore, the aim of this study was to evaluate the agreement 
and validity of selected categories of procedure codes “clean 
colon”, “colonoscopy performed”, “overall completeness of 
colonoscopy”, “incomplete colonoscopy”, “polypectomy”, 
“tumor tissue left behind”, “number of polyps”, “lost polyps” 
and “risk group of polyps” and diagnosis codes “colorectal 
cancer and polyps/benign tumor”, comparing DCCSD data 
with hospital records.
Methods
Study population and setting
The screening program is implemented over a period of 
4 years (2014–2017). Home sampling kits are delivered by 
mail along with instructions and an invitation letter. The 
target population is invited according to a randomly assigned 
sequence of birth months, although citizens, who turn 50 or 
74 years old within the initial 4-year screening round, have 
to receive their first invitation no later than 1 month before 
that particular birthday.
This study was based on 111,810 citizens invited to colorec-
tal cancer screening, via the IAM, between March 3, and May 
31, 2014. In this period, a pilot report of the DCCSD estimated 
that 58% participated by returning for the iFOBT within 3 
months and 6.9% of the analyzed samples were positive.5
Individuals with negative or faulty screening tests were 
not registered in the DNPR with any of the diagnosis and 
procedure codes we aimed to validate, and therefore we only 
included participants with a positive iFOBT result. Thus, 
4,704 individuals with a positive test result were eligible 
for the study. From these, we selected a random sample of 
150 individuals using simple random sampling within strata 
of gender, age and region of residence. The sample consisted 
of 15 men and 15 women from each of the five Danish 
Regions, while also ensuring a distribution of 10 individuals 
from the youngest age group (50–59 years) and 20 from the 
oldest (60–74 years) in each region.
Data
The validated data include a large number of separate codes 
constituting in total 11 categories of procedures and diagnoses 
related to colorectal cancer screening (Table 1). Data are linked 
by a personal registration number (Central Person Registry 
[CPR] number), which is a unique 10-digit number assigned 
to each Danish resident at birth or upon immigration.6 The 
DCCSD was accepted as a clinical quality database in October 
2014 by the Danish Health Data Authority (14/23440) and 
approved by the Danish Data Protection Agency (2007-58-
0014); thus, the study complied with Danish regulations.
The Danish regions’ IAM
The IAM was established in addition to the screening pro-
gram and handles invitations as well as response letters to 
all residents included in the program. Each region can adjust 
the invitation rate in order to accommodate regional capacity 
(especially during the initial implementation).7 The IAM is 
Table 1 Categories of codes for diagnoses and procedures 
included in the validation of the DCCSD
Category Code
Clean colon AFX02C, AFX02D
Colorectal cancer DC180, DC182, DC183, DC184, DC185, 
DC186, DC187, DC189, DC209
Polyps/benign tumors DD120, DD122, DD123A, DD123, 
DD123B, DD124, DD125, DD126C, 
DD128
Colonoscopy performed KUJF32, KUJF35
Overall completeness of 
colonoscopy
ZPY1A0, ZPY1A1, ZPY1A10, ZPY1A11, 
ZPY1A12, ZPY1A13, ZPY1A14, ZPY1A15, 
ZPY1A18
Incomplete colonoscopy ZPY1A1, ZPY1A10, ZPY1A11, ZPY1A12, 
ZPY1A13, ZPY1A14, ZPY1A15, ZPY1A18
Polypectomy KJFA15, KJFA55A, KJFA55B, KJGA05, 
KJGA52A, KJGA52B
Tumor tissue left behind ZPY1B01, ZPY1B02
Number of polyps seen ZPY1Cnn, ZPY1C99
Lost polyps ZPY1D00, ZPY1Dnn, ZPY1D99
Risk group of polyps ZPY1E01, ZPY1E02, ZPY1E03
Abbreviation: DCCSD, Danish Colorectal Cancer Screening Database.
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updated daily with information on vital status, addresses, etc 
from the Civil Registration System.8,9
From the IAM, we retrieved the CPR numbers and data 
of all patients eligible for the study population, by November 
2014.
The DNPR
The DNPR covers all somatic admissions to Danish hospitals 
since 1977 and outpatient contacts since 1995. Information 
in the DNPR includes CPR number, dates of admission and 
discharge, as well as codes for diagnoses (the International 
Classification of Diseases, tenth edition [ICD-10]) and pro-
cedures. Data are collected for administrative purposes, as 
well as for research and quality assurance.10,11 DNPR data for 
this study were retrieved on February 10, 2015.
Hospital record review
A review of the hospital record of each study participant 
was performed according to a standardized protocol by 
an appointed medical doctor in each region. The review-
ers extracted the information on all relevant diagnoses and 
procedures from the medical files and entered them in a 
standardized spreadsheet.
Statistics
We used data from the hospital records as the reference and 
compared these data for each patient with DCCSD data. 
Agreement was calculated as the percent of cases with the 
same coding for diagnoses and procedures in the DCCSD as 
in the hospital records. In addition, we calculated sensitiv-
ity, specificity, positive predictive value (PPV) and negative 
predictive value (NPV).
Sensitivity is the ability of the DCCSD to identify all 
true positives, ie, participants with a diagnosis or procedure 
code for the phenomenon of interest registered in the DCCSD 
and in the hospital records. Sensitivity was calculated as the 
proportion of true positives in the DCCSD out of all positives 
in the hospital records.
Specificity is the ability of the DCCSD to identify all 
true negatives, ie, participants who are not registered with a 
diagnosis or procedure code for the phenomenon of interest 
neither in the DCCSD nor in the hospital records. Specific-
ity was calculated as the proportion of true negatives in the 
DCCSD out of all negatives in the hospital records.
The PPV, which is the probability that a code in the 
DCCSD is correctly registered compared to the hospital 
records, was calculated as the proportion of true positives 
out of all positives in the DCCSD. The NPV, which is the 
probability that a code absent in the DCCSD is correctly 
absent, was calculated as the proportion of true negatives 
out of all negatives in the DCCSD.12 Exact 95% confidence 
intervals (CIs) for the binomial distribution were calculated 
for each estimate.
First, results are presented for 11 categories of codes 
(Table 2). As multiple codes can be used, eg, to indicate can-
cer at several locations in the colon, we examined whether 
a code included in the specific category was recorded – not 
whether it was the correct code. Second, we estimated the 
validity of each code separately (Table 3). Thus, the validity 
of the codes in the DCCSD, eg, cancer, was evaluated as both 
1) overall colorectal cancer, not distinguishing between the 
nine separate diagnosis codes (Table 2), and 2) subtypes of 
cancer, eg, cancer in cecum (DC180; Table 3). For the separate 
procedure and diagnosis codes, we estimated only the agree-
ment, specificity and NPV as the numbers were too sparse to 
estimate meaningful sensitivity and PPV. For completeness 
of colonoscopy, two categories are presented in Table 2, one 
for all codes on completeness of colonoscopy “overall com-
pleteness” and one for the codes that indicate an incomplete 
procedure “incomplete colonoscopy”. For “number of polyps 
seen” and “lost polyps”, “nn” in the codes ZPY1Cnn and 
ZPY1Dnn were replaced by numbers representing the number 
of polyps seen and the size of polyps lost, respectively. If the 
number in the DCCSD was incorrect, the code was treated as 
missing in the calculations of validity of the specific codes.
Results
Of the 150 individuals selected for this validation study, hos-
pital records were available for review for 136 (91%). Records 
for seven patients were not relevant as no colonoscopy was 
performed, and seven records were not accessible (Figure 1). 
For the overall category “clean colon” at both colonoscopy 
and computed tomography (CT) colonography, we found an 
agreement between the DCCSD and the hospital records of 
82.4% (95% CI: 74.9–88.4). Sensitivity was 69.0% (95% CI: 
56.9–79.5) due to 22 false negatives. PPV was 96.1% (95% 
CI: 86.5–99.5), so indicating that this code was rarely recorded 
in the DCCSD if the statement of “clean colon” was not found 
in the hospital records. NPV was 74.1% (95% CI: 63.5–83.0; 
Table 2). For the category “colorectal cancer”, the agreement 
between the DCCSD and the hospital records was 97.1% 
(95% CI: 92.6–99.2), but three false negatives resulted in a 
sensitivity of 72.7% (95% CI: 39.0–94.0). Specificity, NPV 
and PPV were 99.2% (95% CI: 95.6–100.0), 97.6% (95% 
CI: 93.3–99.5) and 88.9% (95% CI: 51.8–99.7), respectively 
(Table 2). The agreement in registration of individual types of 
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cancers ranged between 98.5% and 100%. For the category 
“colonoscopy performed”, the agreement between the DCCSD 
and the hospital records was 96.3% (95% CI: 91.6–98.8). Sen-
sitivity and PPV were 98.5% (95% CI: 94.6–99.8) and 97.7% 
(95% CI: 93.5–99.5), respectively (Table 2). For the category 
“overall completeness of the colonoscopy” (both complete and 
incomplete), the agreement was 92.6% (95% CI: 86.9–96.4) 
and sensitivity was 93.9% (95% CI: 88.4–97.3). Only 60% of 
colonoscopies in the category “incomplete” were reported to 
the DCCSD (sensitivity, 60%; 95% CI: 26.2–87.8). Specific-
ity was above 99%. Thus, the code for incompleteness was 
only in one instance reported to the DCCSD, although the 
colonoscopy was in fact complete (Table 2). For the overall 
category of “polypectomy”, sensitivity and specificity were 
92.1% (95% CI: 82.4–97.4) and 98.6% (95% CI: 92.6–100.0), 
respectively (Table 2). Most polypectomies were of the type 
“endoscopic polypectomies, large intestine” (KJFA15), which 
had an agreement of 95.6% (95% CI: 90.6–98.4; Table 3). 
Overall sensitivity for the category “tumor tissue left behind” 
(including both “tissue left behind” and “no tissue left behind”) 
was 75% (95% CI: 63.0–84.79; Table 2). For the categories 
“number of polyps seen” and “lost polyps”, sensitivity was 
89.4% (95% CI: 79.4–95.6) and 81.5% (95% CI: 68.6–90.7), 
respectively. Agreement for the specific “number of polyps 
seen” (ZPY1Cnn) was 90.4% (95% CI: 84.2–94.8), and for 
the “number of lost polyps” (ZPY1D00) it was 87.5% (95% 
CI: 80.7–92.5; Table 3). Information on “risk group of polyps” 
had an agreement of 83.8% (95% CI: 76.5–89.6), whereas the 
sensitivity was 69.9% (95% CI: 55.9–81.2) due to 17 false 
negatives (Table 2).
Overall, the agreement for the individual diagnosis and 
procedure codes varied from 84% (“clean colon at colonos-
copy” [AF02C]) to 100% (“cancer in cecum” [DC180] and 
“benign tumor in descending colon” [DD124]; Table 3). 
For most individual codes, the specificity was above 95%; 
however, for “colonoscopy” (KUJF32) and “complete colo-
noscopy” (ZPY1A0), four cases were false negatives; thus, 
the specificity was 75.0% (95% CI: 47.6–92.7) and 71.4% 
(95% CI: 41.9–91.6), respectively. The NPVs for the majority 
of the individual codes were 92% or above; however, for the 
codes “clean colon at colonoscopy” (AFX02C), “colonos-
copy” (KUJF32) and “complete colonoscopy” (ZPY1A0), 
the NPVs were 77.0% (95% CI: 66.8–85.4), 48.0% (95% 
CI: 27.8–68.7) and 58.8% (95% CI: 32.9–81.6), respectively.
Discussion
We had access to hospital records for >95% of the 143 
sampled individuals, who had had a colonoscopy performed; 
Table 2 Validity of categories of colorectal cancer screening codes in the DCCSD compared with hospital records, n=136
Categories Agreement, %  
(95% CI); a/n
Sensitivity, %  
(95% CI);  
tp/(tp+fn)
Specificity, %  
(95% CI);  
tn/(tn+fp)
PPV, %  
(95% CI); 
 tp/(tp+fp)
NPV, % (95% CI); 
tn/(tn+fn)
Clean colon 82.4 (74.9–88.4); 
112/136
69.0 (56.9–79.5);  
49/(49+22)
96.9 (89.3–99.6);  
63/(63+2)
96.1 (86.5–99.5); 
49/(49+2)
74.1 (63.5–83.0); 
63/(63+22)
Colorectal cancer 97.1 (92.6–99.2); 
132/136
72.7 (39.0–94.0);  
8/(8+3)
99.2 (95.6–100.0);  
124/(124/1)
88.9 (51.8–99.7);  
8/(8+1)
97.6 (93.3–99.5); 
124/(124+3)
Polyps/benign tumors 90.4 (84.2–94.8); 
123/136
84.7 (73.0–92.8);  
50/(50+9)
94.8 (87.2–98.6);  
73/(73+4)
92.6 (82.1–97.9);  
50/(50+4)
89.0 (80.2–94.9); 
73/(73+9)
Colonoscopy performed 96.3 (91.6–98.8); 
131/136
98.5 (94.6–99.8);  
130/(130+2)
25.0 (0.6–80.6);  
1/(1+3)
97.7 (93.5–99.5);  
130/(130+3)
33.3 (0.8–90.6);  
1/(1+2)
Overall completeness of 
colonoscopy
92.6 (86.9–96.4); 
126/136
93.9 (88.4–97.3);  
124/(124+8)
50.0 (6.8–93.2);  
2/(2+2)
98.4 (94.4–99.8);  
124/(124+2)
20.0 (2.5–55.6);  
2/(2+8)
Incomplete colonoscopy 96.3 (91.6–98.8); 
131/136
60.0 (26.2–87.8);  
6/(6+4)
99.2 (95.7–100.0);  
125/(125+1)
85.7 (42.1–99.6);  
6/(6+1)
96.9 (92.3–99.1); 
125/(125+4)
Polypectomy 95.6 (90.6–98.4); 
130/136
92.1 (82.4–97.4);  
58/(58+5)
98.6 (92.6–100.0);  
72/(72+1)
98.3 (90.9–100.0);  
58/(58+1)
93.5 (85.5–97.9); 
72/(72+5)
Tumor tissue left behind 87.5 (80.7–92.5); 
119/136
75.0 (63.0–84.7);  
51/(51+17)
100.0 (94.7–100.0);  
68/(68+0)
100.0 (93.0–100.0);  
51/(51+0)
80.0 (69.9–87.9); 
68/(68+17)
Number of polyps seen 93.4 (87.8–96.9); 
127/136
89.4 (79.4–95.6);  
59/(59+7)
97.1 (90.1–99.7);  
68/(68+2)
96.7 (88.7–99.6);  
59/(59+2)
90.7 (81.7–96.2); 
68/(68+7)
Lost polyps 88.2 (81.6–93.1); 
120/136
81.5 (68.6–90.7);  
44/(44+10)
92.7 (84.8–97.3);  
76/(76+6)
88.0 (75.7–95.5);  
44/(44+6)
88.4 (79.7–94.3); 
76/(76+10)
Risk group of polyps 83.8 (76.5–89.6); 
114/136
69.6 (55.9–81.2);  
39/(39+17)
93.8 (86.0–97.9);  
75/(75+5)
88.6 (75.4–96.2);  
39/(39+5)
81.5 (72.1–88.9); 
75/(75+17)
Notes: a, number in agreement; n, number in total.
Abbreviations: CI, confidence interval; fn, false negatives; fp, false positives; NPV, negative predictive value; PPV, positive predictive value; tn, true negatives; tp, true 
positives.
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Table 3 Validity of specific colorectal cancer screening codes in the DCCSD compared with hospital records, n=136
DCCSD 
code
Agreement, %  
(95% CI); a/n
Specificity, % (95% CI);  
tn/(tn+fp)
NPV, % (95% CI); tn/(tn+fn)
Clean colon at colonoscopy AFX02C 83.8 (76.5–89.6); 114/136 97.1 (89.9–99.6); 67/(67+2) 77.0 (66.8–85.4); 67/(67+20)
Clean colon at CT colonography AFX02D 97.8 (93.7–99.5); 133/136 100.0 (97.2–100.0); 131/(131+0) 97.8 (93.6–99.5); 131/(131+3)
Cancer in cecum DC180 100.0 (97.3–100.0); 136/136 100.0 (97.3–100.0); 135/(135+0) 100.0 (97.3–100.0); 135/(135+0)
Cancer in ascending colon DC182 99.3 (96.0–100.0); 135/136 100.0 (97.3–100.0); 135/(135+0) 99.3 (96.0–100.0); 135/(135+1)
Cancer in transverse colon DC184 99.3 (96.0–100.0); 135/136 100.0 (97.3–100.0); 134/(134+0) 99.3 (95.9–100.0); 134/(134+1)
Cancer in sigmoid colon DC187 98.5 (94.8–99.8); 134/136 99.2 (95.9–100.0); 131/(131+1) 99.2 (95.9–100.0); 131/(131+1)
Colorectal cancer unspecified DC189 98.5 (94.8–99.8); 134/136 98.5 (94.8–99.8); 134/(134+2) 100.0 (97.3–100.0); 134/(134+0)
Rectal cancer DC209 99.3 (96.0–100.0); 135/136 100.0 (97.3–100.0); 133/(133+0) 99.3 (95.9–100.0); 133/(133+1)
Benign tumor in cecum DD120 96.3 (91.6–98.8); 131/136 99.2 (95.8–100.0); 128/(128+1) 97.0 (92.4–99.2); 128/(128+4)
Benign tumor in ascending colon DD122 97.1 (92.6–99.2); 132/136 99.2 (95.8–100.0); 130/(130+1) 97.7 (93.5–99.5); 130/(130+3)
Benign tumor in right colic  
flexure
DD123A 98.5 (94.8–99.8); 134/136 99.2 (95.9–100.0); 132/(132+1) 99.2 (95.9–100.0); 132/(132+1)
Benign tumor in transverse colon DD123 98.5 (94.8–99.8); 134/136 99.2 (95.8–100.0); 129/(129+1) 99.2 (95.8–100.0); 129/(129+1)
Benign tumor in left colic flexure DD123B 97.8 (93.7–99.5); 133/136 98.5 (94.7–99.8); 131/(131+2) 99.2 (95.9–100.0); 131/(131+1)
Benign tumor in descending  
colon
DD124 100.0 (97.3–100.0); 136/136 100.0 (97.3–100.0); 133/(133+0) 100.0 (97.3–100.0); 133/(133+0)
Benign tumor in sigmoid colon DD125 93.4 (87.8–96.9); 127/136 97.9 (92.5–99.7); 92/(92+2) 92.9 (86.0–97.1); 92/(92+7)
Multiple benign tumors in the  
colon
DD126C 99.3 (96.0–100.0); 135/136 100.0 (97.3–100.0); 133/(133+0) 99.3 (95.9–100.0); 133/(133+1)
Benign tumor in the rectum DD128 94.9 (89.7–97.9); 129/136 97.5 (92.9–99.5); 118/(118+3) 96.7 (91.8–99.1) 118/(118+4)
Colonoscopy KUJF32 87.5 (80.7–92.5); 119/136 75.0 (47.6–92.7); 12/(12+4) 48.0 (27.8–68.7); 12/(12+13)
Colonoscopy with biopsy KUJF35 89.7 (83.3–94.3); 122/136 90.3 (83.7–94.9); 112/(112+12) 98.2 (93.8–99.8); 112/(112+2)
Complete colonoscopy ZPY1A0 91.9 (86.0–95.9); 125/136 71.4 (41.9–91.6); 10/(10+4) 58.8 (32.9–81.6); 10/(10+7)
Not complete colonoscopy ZPY1A1 98.5 (94.8–99.8); 134/136 100.0 (97.3–100.0); 133/(133+0) 98.5 (94.8–99.8); 133/(133+2)
Endoscopic polypectomy, large 
intestine
KJFA15 95.6 (90.6–98.4); 130/136 96.3 (89.6–99.2); 78/(78+3) 96.3 (89.6–99.2); 78/(78+3)
Endoscopic mucosal resection,  
large intestine
KJFA55A 98.5 (94.8–99.8); 134/136 99.3 (95.9–100.0); 133/(133+1) 99.3 (95.9–100.0); 133/(133+1)
Rectoscopic polypectomy,  
rectum
KJGA05 94.9 (89.7–97.9); 129/136 98.4 (94.3–99.8); 123/(123+2) 96.1 (91.1–98.7); 123/(123+5)
Tumor tissue left behind ZPY1B01 94.9 (89.7–97.9); 129/136 99.2 (95.8–100.0); 128/(128+1) 95.5 (90.5–98.3); 128/(128+6)
No tumor tissue left behind ZPY1B02 89.7 (83.3–94.3); 122/136 98.7 (92.8–100.0); 74/(74+1) 87.1 (78.0–93.4); 74/(74+11)
Number (nn) polyps seen ZPY1Cnn 90.4 (84.2–94.8); 123/136 97.1 (90.1–99.7); 68/(68+2) 86.1 (76.5–92.8); 68/(68+11)
No lost polyps ZPY1D00 87.5 (80.7–92.5); 119/136 94.3 (87.2–98.1); 83/(83+5) 87.4 (79.0–93.3); 83/(83+12)
Largest polyp lost, size in mm ZPY1Dnn 96.3 (91.6–98.8); 131/136 96.9 (92.3–99.2); 126/(126+4) 99.2 (95.7–100.0); 126/(126+1)
High-risk polyps removed ZPY1E01 92.6 (86.9–96.4); 126/136 97.5 (93.0–99.5); 119/(119+3) 94.4 (88.9–97.7); 119/(119+7)
Medium-risk polyps removed ZPY1E02 91.2 (85.1–95.4); 124/136 97.4 (92.7–99.5); 114/(114+3) 92.7 (86.6–96.6); 114/(114+9)
Low-risk polyps removed ZPY1E03 88.2 (81.6–93.1); 120/136 93.8 (87.5–97.5); 105/(105+7) 92.1 (85.5–96.3); 105/(105+9)
Notes: a, number in agreement; n, number in total.
Abbreviations: CI, confidence interval; CT, computed tomography; fn, false negatives; fp, false positives; NPV, negative predictive value; tn, true negatives; tp, true positives.
thus, 136 patients were included in the analysis. In general, 
we found high agreement for categories of diagnosis and 
procedure codes in the DCCSD, when comparing DCCSD 
data with hospital records.
Agreement was highest for “colorectal cancer” (97.1%) 
and lowest for “lost polyps” (88.2%). Sensitivity varied 
between moderate and high with 60.0% for “incomplete 
colonoscopy” and 98.5% for “colonoscopy performed”. 
Specificity was 92.7% or above except for the categories 
“colonoscopy performed” and “overall completeness of 
colonoscopy”, where the specificity was low; however, the 
estimates were imprecise. The low number of false positives 
and the general high specificity indicate that the proportion 
of missing data in the categories of codes in the DCCSD is 
limited. Considering the individual codes, the validity is less 
clear as the estimates are somewhat imprecise.
A major strength of this study is that the study population 
was extracted from the IAM, a registry independent from 
the DNPR. This enabled us not only to validate correctness 
of information of the DNPR data in the DCCSD but also to 
address the degree of missing data, which can lead to under-
estimations. A common limitation of validity studies is that 
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 individuals are identified in the registry which is under review 
and then data are compared with hospital records. When, as 
in this study, the population can be defined from a third and 
complete source, clinical registries and hospital records can 
be compared by calculating specificity and NPVs in addition 
to sensitivity and PPVs.
One limitation of our study is the relatively small sample 
size and especially the low numbers of people with cancer, 
leading to imprecise estimates. Although we used a random 
sample securing data from all regions, gender and ages, the 
136 patients might not be representative of all patients with a 
positive screening test in the Danish colorectal cancer screen-
ing program. It was only possible to have one medical doctor 
to review the hospital records from each region, and therefore 
the results may be subject to an unknown level of imprecise 
extraction of data. The information was delivered in a uniform 
way via a standardized spreadsheet. This means that inter-
pretation mistakes in the communication between reviewers 
and researchers were minimized. We used hospital records as 
the gold standard when evaluating agreement and validity of 
codes recorded in the DCCSD. This approach is typically used 
in validity studies,13 but hospital records do not necessarily 
represent perfect information as information could be miss-
ing or be incorrectly stated. Some of the specific codes had 
lower validity, mainly colonoscopy procedure codes. These 
codes (AFX02C, KUJF32, ZPY1A0, ZPY1B02, ZPY1D00 
and ZPY1E03) were implemented at the start of the screen-
ing program, whereas the remaining codes were already in 
use for registration of colorectal cancer diagnostic workup 
and treatment. As time passes, medical staff will become 
more familiar with the program and the coding procedures 
and definitions described in the clinical guidelines;14 thus, 
the validity of these codes is likely to increase. In addition, 
implementation of the screening program has put pressure 
on colonoscopy units, which may have led to some delays 
in reporting to the DCCSD. If the time period from the end 
of the study to data extraction had been longer, it is possible 
that less data would be missing.
Concerning the specific codes for high-, medium- and 
low-risk polyps removed, numbers of false negatives varied 
from 7 to 9, resulting in a low sensitivity for the category 
“risk group of polyps”. Hence, for future studies includ-
ing data on risk groups, it is recommended also to use the 
pathology data in the DCCSD, which were not included in 
this validation study.
Helqvist et al15 examined the quality of colorectal cancer 
diagnosis codes (2001–2006) in the DNPR. They compared 
DNPR data to the data from the Danish Cancer Registry, 
which has a sensitivity and PPV of >99%.16 Helqvist et al were 
able to include >25,000 people with ICD-10 diagnosis codes 
C18, C19 or C20 for colorectal cancer in their analysis. They 
found a sensitivity of 93.4% and a PPV of 88.9% for overall 
colorectal cancer registration. We found a PPV equal to theirs, 
but a lower sensitivity (72.7%). Because of the small number 
of cancers in our sample, the CIs were wide for both estimates.
When using DCCSD data for quality assessment and 
research purposes, some reservations should be noted. First, 
use of some of the specific codes may result in missing or 
incorrect data, eg, defining a study population based on a 
colonoscopy procedure may result in an incomplete study 
population. A combination of different codes could be used 
to minimize this problem. Second, patients lacking a code in 
the DCCSD (false negatives), as well as patients registered 
with a code in the DCCSD not verified in the hospital records 
(false positives), might differ from other patients in, eg, 
disease severity. This may cause misclassification and bias 
if they differ in relation to the outcome of a specific study.
Conclusion
The high level of agreement between categories of codes 
in the DCCSD and hospital records indicates that DCCSD 
reflects the hospital records well. Further, sensitivity and 
150 individuals
136 hospital records
available for validation
7 individuals resigned
from program,
canceled appointment
or did not show up
7 records not
accessible
Figure 1 Flowchart of hospital records.
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specificity of the categories appear to vary from moderate 
to high. Thus, the DCCSD may be a valuable data source for 
future research on colorectal cancer screening. Considering 
the specific codes, the validity is less clear and therefore the 
risk of missing data should be taken into account when using 
the individual codes for research purposes.
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